← Evidence map

TrialBMC pharmacology & toxicology2015

The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjects.

Bruce E Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

28 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 26092545